Trials / Terminated
TerminatedNCT04286529
Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to study the effects of 1,25(OH)2 D3 (a prescription form of active Vitamin D) on muscle strength and insulin secretion by the pancreas and glucose utilization by skeletal muscle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcitriol capsules | 0.25micrograms, taken daily for eight weeks, orally |
| DRUG | Oral Placebo | Placebo will be created to mimic the appearance of the study drug |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-05-28
- Completion
- 2021-05-28
- First posted
- 2020-02-27
- Last updated
- 2022-04-18
- Results posted
- 2022-04-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04286529. Inclusion in this directory is not an endorsement.